Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Zhejiang Cancer Hospital"
Count: 290
Selected: 0
| NCT ID | Title |
|---|
| NCT05461690 | Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency | ||
| NCT05794841 | Multi-omics Study of Tongue Coating in Malignant Tumors of Digestive Tract | ||
| NCT05651802 | PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients | ||
| NCT02992067 | CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer | ||
| NCT06055816 | Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma | ||
| NCT05228496 | A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC | ||
| NCT06048289 | Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy | ||
| NCT04119674 | Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma | ||
| NCT06046963 | Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites | ||
| NCT06006338 | 3D Printed Models for Liver Surgery | ||
| NCT05992597 | ZR2 Sequential Immunochemotherapy for Newly Treated MCL | ||
| NCT04790409 | Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations | ||
| NCT06031597 | Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy | ||
| NCT05920863 | Lenvatinib Combined With Tislelizumab and TACE Applied as Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma With High-risk Recurrence Factors | ||
| NCT05557578 | GOT Applied as Neoadjuvant Regimen for Patients of Resectable ICC With High-risk Factors of Recurrence | ||
| NCT05212064 | HFNC and Hypoxia During Percutaneous Radiofrequency Ablation Under Conscious Sedation: A Randomized Clinical Trial | ||
| NCT05991947 | Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer | ||
| NCT05985577 | Mechanism of Gastric Signet Ring Cell Carcinoma Based on Microproteomics | ||
| NCT05290090 | ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL | ||
| NCT05974085 | XPO-1 in Combination With RCHOP for DH/TH Lymphoma | ||
| NCT05971199 | Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma | ||
| NCT04808752 | Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases | ||
| NCT05963087 | Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal Cancer | ||
| NCT05958849 | Advanced Pancreatic Cancer | ||
| NCT05928312 | Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer | ||
| NCT02923128 | Whether Dexmedetomidine Can Improve the Prognosis of Elderly Patients With Postoperative Cognitive Dysfunction | ||
| NCT05911425 | Combined Treatment of Treated Bile Duct Cancer | ||
| NCT05903456 | Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma | ||
| NCT05896059 | A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC | ||
| NCT05856383 | Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC | ||
| NCT05126160 | Immune Score Based Radiomics in Nasopharyngeal Carcinoma | ||
| NCT05813626 | Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | ||
| NCT05183958 | A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer | ||
| NCT05705583 | A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma | ||
| NCT04162691 | Single Cell Sequencing Analysis of Thymoma | ||
| NCT05669807 | Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer | ||
| NCT05669092 | A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status | ||
| NCT05007587 | Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC | ||
| NCT05652192 | SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC | ||
| NCT05617469 | DLCS for Predicting Neoadjuvant Chemotherapy Response | ||
| NCT05385809 | A Retrospective Study of Immunotherapy in Conversion Therapy of Unresectable Gastric Cancer | ||
| NCT05596071 | Whether Opioids Are Factor That Induced POD? | ||
| NCT05468671 | Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy | ||
| NCT05564897 | Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer | ||
| NCT05559775 | A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Standard Therapy | ||
| NCT05550090 | Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC | ||
| NCT05544149 | TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors | ||
| NCT05489926 | A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure | ||
| NCT05528367 | Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | ||
| NCT05514275 | Radiotherapy Combined With Endostatin and Capecitabine for NPC |
